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Abstract
Background: Hypertensive nephrosclerosis is the second most common cause of end-stage renal
failure in the United States. The mechanism by which hypertension produces renal failure is
incompletely understood. Recent evidence demonstrated that an unscheduled and inappropriate
increase in apoptosis occurred in the Dahl/Rapp rat, an inbred strain of rat that uniformly develops
hypertension and hypertensive nephrosclerosis; early correction of the hypertension prevents the
renal injury. The present study examined the role of the Fas/FasL pathway in this process.
Methods: Young male Dahl/Rapp salt-sensitive (S) and Sprague-Dawley rats were fed diets that
contained 0.3% or 8.0% NaCl diets. Kidneys were examined at days 7 and 21 of the study.
Results:  An increase in Fas and FasL expression was observed in glomerular and tubular
compartments of kidneys of hypertensive S rats, whereas dietary salt did not change expression of
either of these molecules in normotensive Sprague-Dawley rats. Associated with this increase was
cleavage of Bid and activation of caspase-8, the initiator caspase in this apoptotic pathway, by day
21 of the study.
Conclusions: Augmented expression of apoptotic signaling by the Fas/FasL pathway occurred
during development of end-stage renal failure in this model of hypertensive nephrosclerosis.
Background
Hypertension is a common medical problem in the Unit-
ed States, occurring in as many as 43 million individuals
[1]. While end-stage renal failure represents the second
most common cause of end-stage renal disease [2], per-
haps only 1 in 2,500 hypertensive patients develops clin-
ically important hypertensive nephrosclerosis. This low
frequency of end-organ renal damage suggests a potential
predisposition to this complication. The inbred Dahl/
Rapp rat is a genetic model of salt-sensitive hypertension
[3,4]. On a diet containing 8.0% NaCl, young Dahl/Rapp
salt-sensitive (S) rats rapidly and uniformly manifest low-
renin hypertension and die from hypertensive nephro-
sclerosis within weeks of institution of the high-salt diet
[5]. The pathology is identical to human hypertensive re-
nal disease and consists of arteriolosclerosis, glomerulo-
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sclerosis, and interstitial scarring with tubular cell
dropout. While other animal models of hypertension can
be employed to study the pathogenesis of hypertension,
because of the rapid and reproducible development of re-
nal failure, S rats provide a unique means to investigate
the pathogenesis of hypertensive nephrosclerosis. In this
respect, this model is very useful in understanding hyper-
tensive nephrosclerosis that occurs in human low-renin
hypertension, especially in defined, more homogeneous
populations such as the black patients described by Grim
and associates [6].
Recent studies have shown that apoptosis was accentuated
in kidneys of S rats during development of nephrosclero-
sis [7]. These studies demonstrated increased numbers of
TUNEL-positive cells, increased cytoplasmic nucleosome
content and caspase-3 activation in kidneys of hyperten-
sive S rats, compared to normotensive Sprague-Dawley
control rats on the same high-salt diet. An increase in ap-
optosis rates in glomeruli and tubules was observed, con-
firming a process that involved several different cell types
in the kidney. Apoptotic bodies were noted particularly in
areas of glomerular sclerosis and in dilated tubules. An in-
crease in the number of PCNA-stained cells was also dem-
onstrated during the 21-day time frame, but because renal
function deteriorated, renal failure correlated therefore
positively with apoptosis and inversely with proliferation
rates. Thus, the apoptotic process appeared to be a strong
determinant of outcome in this model.
The Fas/FasL system transmits apoptotic signals from the
surrounding environment into the cell. Fas contains a sin-
gle transmembrane domain and belongs to the tumor
necrosis factor (TNF)/nerve growth factor family [8]. FasL
contains a single transmembrane domain and is also a
member of the same TNF family [9]. A soluble form of
FasL has been described, but appears to be less capable of
inducing apoptosis, when compared with the bound form
[10,11]. The binding of FasL with Fas initiates receptor ol-
igomerization, which recruits Fas-associated death do-
main (FADD) [12]. FADD binds procaspase-8 and
permits activation of caspase-8 through self-cleavage [13].
Caspase-8 activates the effector caspases, which commits
the cell to the orderly process of apoptosis [14,15]. In ad-
dition, caspase-8 cleaves Bcl-2-interactive-death-agonist
(Bid) [16]. Truncated Bid localizes to the mitochondria
and promotes cytochrome c release; this process also
serves as a major apoptotic-signaling pathway for Fas [16–
18]. Depending upon the amount of caspase-8 that is ac-
tivated, the predominant pathway can be either Bid cleav-
age with subsequent mitochondrial release of cytochrome
c or activation of the effector caspase pathway [18]. Resi-
dent cells of the kidney express both Fas and FasL and Fas/
FasL signaling is functional in these cells [19–24]. A recent
review by Ortiz and associates [25] noted that the com-
bined literature demonstrating participation of Fas/FasL
pathway in renal injury essentially fulfilled Koch's postu-
lates.
In kidneys of S rats, associated with apoptosis was a tem-
poral increase in expression of Fas, which was demon-
strated using Western analysis of lysates of kidney cortex
[7]. The purpose of the present study was to demonstrate
the site of expression and potential functional significance
of Fas and FasL in the kidneys of S rats during develop-
ment of hypertensive nephrosclerosis.
Materials and Methods
Animal preparation
Studies were conducted using 40 male Dahl/Rapp salt-
sensitive (SS/Jr, termed S) and 40 male Sprague-Dawley
(SD) rats, initially 28 days of age, obtained from Harlan
Sprague Dawley, Indianapolis, IN. The rats were housed
under standard conditions and given a formulated diet
(AIN-76A, Dyets, Inc., Bethlehem, PA) that contained ei-
ther 0.3% or 8.0% NaCl. These diets were prepared specif-
ically to be identical in protein and electrolyte
composition and differed only in NaCl and sucrose con-
tent. Groups of S and SD rats on 0.3% and 8.0% NaCl
were maintained contemporaneously for each of the ex-
periments performed. On days 7 and 21 of study, rats
from all the groups were anesthetized by intraperitoneal
injection of sodium pentobarbital (Abbott Laboratories,
North Chicago, IL), 50 mg/kg. Laparotomy was per-
formed and the kidneys were perfused in situ through the
aorta with cold heparinized 0.9% NaCl solution until
blanching occurred, which generally required infusion of
50 to 60 ml saline over 2 min. Both kidneys were harvest-
ed under sterile conditions to obtain protein for Western
analysis and for light microscopy and histochemistry after
fixation in 4% paraformaldehyde in PBS.
In situ detection of DNA fragmentation using TUNEL
In situ detection of DNA fragmentation was performed by
incorporation of fluorescein-12-dUTP at the 3'-OH ends
of DNA using Terminal deoxynucleotidyl Transferase
(TUNEL assay) (Apoptosis Detection System, Fluorescein,
Promega, Madison, WI), as performed previously by this
laboratory [7,26]. Nuclei were counterstained using pro-
pidium iodide (Sigma Chemical Co., St. Louis, MO). For
fluorescein, the excitation and barrier filters were set at
450–490 and 515–560 nm, respectively. Red fluorescence
of propidium iodide was observed using excitation and
barrier filters of 515–560 and 580 nm, respectively.
Immunohistochemistry
After embedding in paraffin, sections 5 µm in thickness
were immersed twice into xylene for 5 min each, followed
by immersion twice for 3 min each in 100% ethanol and
then 95% ethanol. Slides were rinsed for 30 sec usingBMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/1
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deionized water and then immersed twice in deionized
water for 5 min. To detect Fas, tissue sections were initially
treated with 1% SDS in TBS (100 mM Tris-HCl, pH 7.4,
138 mM NaCl and 27 mM KCl) for 5 min at room tem-
perature, followed by three 5-min washes in TBS alone.
Slides were covered in 0.1–1.0% H2O2 for 5 min at room
temperature and incubated in goat serum for 30 minutes
at room temperature. Slides were incubated for 30 min-
utes at room temperature in PBS containing monoclonal
mouse anti-human Fas/CD95/APO-1 (Transduction Lab-
oratories, Lexington, Kentucky), 0.5–1.0 µg/ml, and 10%
goat serum. Slides were rinsed and covered with TBS con-
taining 10% rat serum and peroxidase-labeled polymer
conjugated to goat anti-mouse IgG (DAKO EnVision™+
System, DAKO Corporation, Carpinteria, CA) for 30 min-
utes at room temperature and color was developed using
3,3'-diaminobenzidine (DAB) Chromogen solution (DA-
KO). Cells were counterstained using hematoxylin and
the slides were mounted in standard fashion. As a negative
control, the primary antibody was omitted from the reac-
tion. As an additional control, the anti-Fas antibody was
pre-incubated with recombinant soluble human Fas
(PharMingen, San Diego, CA), 0.5 µg/ml, for 1 h at room
temperature prior to use as the primary antibody to stain
the specimens. To detect FasL, paraffin-embedded sec-
tions were initially heated twice at 95°C for 5 min in 10-
mM sodium citrate buffer, pH 6.0. Staining then proceed-
ed in standard fashion using goat polyclonal anti-FasL an-
tibody (goat polyclonal antibody IgG raised against
FasL(N-20), Santa Cruz Biotechnology, Inc., Santa Cruz,
CA), 1–4 µg/ml, followed by biotinylated donkey anti-
goat IgG. Color was developed using the avidin-biotin de-
tection system (ImmunoCruz Staining Systems, Santa
Cruz Biotechnology, Inc.).
Immunoenzyme double staining of kidney tissue was per-
formed using DAKO EnVision Doublestain System (DA-
KO). The sections were initially heated twice at 95°C for 5
min in 10-mM sodium citrate buffer, pH 6.0, and then in-
cubated for 30 min with the mouse anti-Fas IgG (Trans-
duction Laboratories), 1:500 dilution in PBS containing
1% BSA. The sections were incubated in horseradish per-
oxidase-conjugated goat anti-rabbit and goat anti-mouse
immunoglobulins for 30 min and developed with 3,3'-di-
aminobenzidine (DAB) Chromogen solution (DAKO).
After incubation for 10 min in the Doublestain Block
(DAKO) at room temperature, the specimens were incu-
bated for 30 min with the goat anti-FasL IgG (Santa Cruz
Biotechnology, Inc.), 1:50 dilution in PBS containing 1%
BSA. The samples were then incubated with alkaline phos-
phatase-conjugated goat anti-rabbit IgG and goat anti-
mouse IgG for 30 min. The slides were developed using al-
kaline-phosphatase substrate to produce the red color.
The sections were then counterstained using hematoxylin
before study.
The specimens were examined using a light microscope
(Leica, Germany) equipped with a digital camera (Model
C5810, Hamamatsu Photonics K.K.). Semi-quantification
of stained tubular epithelial cells was determined at × 20
magnification by projecting the image and counting the
number of positive cells; a total of six different fields were
analyzed for each kidney and the results were averaged to
produce a final count for each kidney. Quantification of
staining of glomerular compartment was determined at
× 20 magnification by counting the number of stained
cells in twenty-five glomeruli.
Immunoblot analysis
Samples of renal cortex from S and SD rats on the 0.3%
and 8.0% NaCl diets for 7 and 21 days were diced into
small pieces and chilled in 3 ml of ice cold RIPA buffer per
gram of tissue, then homogenized (Omni-Mixer 17105;
Omni, Waterbury, CT) in standard fashion. Reagents were
from Sigma Chemical Co. The solutions were mixed gen-
tly and incubated on ice for 30 min, then homogenized by
passage through 21-gauge needle. Thirty µl of phenyl-
methylsulfonyl fluoride (PMSF), 10 mg/ml, was added
per gram of tissue and incubated on ice for 30 min. Sam-
ples were centrifuged at 15,000 × g for 20 min at 4°C and
the supernatant was harvested. Total protein of each sam-
ple was determined using a kit (Micro BCA protein assay
reagent kit, Pierce, Rockford, IL.). For each experiment
that examined a protein of interest, all samples were proc-
essed simultaneously. Samples containing 60 µg of total
protein were mixed with an equal volume of 2x SDS-Lae-
mmli sample buffer (100 mM Tris-HCl, pH 6.8, 20% glyc-
erol, 200 mM dithiothreitol, 4% SDS, and 0.2%
bromphenol blue) and boiled for 5 min, then resolved us-
ing either 12% SDS-polyacrylamide gel electrophoresis.
Proteins were transferred on to nitrocellulose membrane
using an electroblotting apparatus (Bio-Rad, Richmond,
CA). Following incubation in blocking buffer (10 mM
Tris-HCl, pH 7.5, containing 10% non-fat dry milk, 100
mM NaCl, and 0.1% Tween 20), the membranes were
probed with an affinity-purified rabbit polyclonal IgG di-
rected against caspase-8 (Caspase-8 p20, Santa Cruz Bio-
technology, Inc., Santa Cruz, CA), 1:200 dilution in
blocking buffer, overnight at 4°C. The membranes were
then washed five times with TBS-Tween and were incubat-
ed with horseradish peroxidase-conjugated donkey anti-
rabbit IgG (Bio-Rad, Hercules, CA), 1:5,000 dilution. Af-
ter three additional washes using TBS-Tween, the mem-
brane was developed using ECL Western blotting system
and Hyperfilm (Amersham Pharmacia Biotech, Piscata-
way, NJ). The antibody used in these studies recognized
bands of the expected size for pro-caspase-8 (about 55
kDa) and active caspase-8 (about 20 kDa). In other exper-
iments, samples containing 80 µg total protein underwent
SDS-PAGE using 15% polyacrylamide gels. The samples
were transferred on to nitrocellulose membranes, whichBMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/1
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Figure 1
Representative light micrograph (top panel) of a kidney from an S rat that had been on 8.0% NaCl diet for three weeks. The fig-
ure shows typical hypertensive renal lesions, which include thickening of the arteriolar wall (arrow), glomerular sclerosis, and
dilatation of tubules with tubular atrophy (asterisks) and presence of cast material (C) in some tubules. Expansion of the inter-
stitium, indicated by an increase in the distance between the tubules, was also evident. H/E stain. Black bar represented 50 µm.
The dual immunofluorescent studies at the bottom show how exuberant the apoptotic process can be in this model. The bot-
tom left panel represents a section that was counterstained with propidium iodide to label the nuclei (red color). The middle
panel is the same section that was stained using the TUNEL assay, which fluorescein-labels the 3'-OH termini of DNA. Several
nuclei in the tubular and glomerular compartments demonstrate the green fluorescence. The bottom right panel is a combined
image; the yellow color is the result of overlapping propidium iodide and fluorescein labeling. White bar represented 50 µm.
Arrowheads denote glomerulus.BMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/1
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were incubated in blocking buffer (TBS, pH 7.5, contain-
ing 10% dried milk and 0.1% Tween-20) and then rabbit
anti-Bid antiserum (BD PharMingen, San Diego, CA),
1:2000 dilution in the same blocking buffer, at 4°C, over-
night. Following incubation with donkey anti-rabbit IgG
conjugated with horseradish peroxidase (Santa Cruz Bio-
technology Inc. Santa Cruz, CA), 1:6000 dilution, for 1 h
at room temperature, the membrane was developed as de-
scribed above.
Statistical analysis
All data were presented as mean ± standard error. Signifi-
cant differences were determined using one-way analysis
of variance with standard post-hoc testing (Statview, ver-
sion 5.0, SAS Institute, Cary, NC). A P value of < 0.05 as-
signed statistical significance.
Results
Kidneys of S and SD rats on both 0.3% and 8.0% NaCl di-
ets were examined on days 7 and 21. The blood pressure
responses to dietary salt intake of the Dahl/Rapp S rat, an
experimental model of hypertensive nephrosclerosis, and
of the SD strain of rat have been published. After seven
days on the high salt diet, S rats were hypertensive (146 ±
2 mm Hg) but had preserved renal morphology [5]. By
day 21 on the 8.0% NaCl diet, the mean blood pressure
increased to 169 ± 7 mm Hg [7,27,28]. Mean blood pres-
sures of SD rats were not influenced by intake of salt over
this time frame of study (118 ± 4 mm Hg on the 8.0%
NaCl diet, compared to 115 ± 4 mm Hg on the 0.3% NaCl
diet). In addition, SD animals were healthy, the intake of
either diet was similar, and they demonstrated no renal
abnormalities [27–29]. In the present study, by day 21 the
kidneys of S rats demonstrated significant vascular,
glomerular and tubulo-interstitial injury. TUNEL demon-
strated apoptosis in glomerular and tubular compart-
ments (Fig 1). SD rats on both diets and S rats on 0.3%
NaCl diet demonstrated by light microscopy no renal
morphological alterations over the same period of study.
These findings were similar to previous publications from
this laboratory [5,7].
Using immunohistochemistry, expression of Fas was in-
creased specifically in kidneys of S rats on 8.0% NaCl diet
by day 7 (Fig. 2). Staining was inhibited when the anti-Fas
antibody was pre-incubated with recombinant soluble Fas
(Fig. 2E and 2J). Quantification analysis comparing the
four groups of rats in the study showed that expression of
Fas in glomerular and tubular cells was greatest (P < 0.05)
in kidneys of S rats exposed to the 8.0% NaCl diet for 7
and 21 days (Fig. 3). Comparing animals on the two diets
for the same duration, dietary salt did not alter Fas expres-
sion in kidneys of SD rats. The increase in Fas expression
in kidneys of S rats on the 8.0% NaCl diet was observed in
cells in the glomeruli, tubules and arteries (Fig. 4A,B,C).
Cytoplasmic staining was particularly apparent in these
samples.
Over the same time period, FasL expression was also ex-
amined (Fig. 5A,B,C,D,E,F,G,H,I,J). The anti-FasL anti-
body labeled cells in both glomerular and tubular
compartments, but expression was more subtle than Fas,
particularly in the glomeruli. Quantification of these ob-
servations showed an increase in expression of FasL in
both glomerular and tubular compartments of kidneys of
S rats on the 8.0% NaCl diet, compared with the other
three groups (Fig. 6). Again, dietary salt did not alter
glomerular and tubular expression of FasL in kidneys of
SD rats. Tubular epithelial cell expression of FasL ap-
peared to be predominantly apical (Fig. 4D and 4E), al-
though cytoplasmic staining was also observed,
particularly in cells of S rats on the 8.0% NaCl diet. In ad-
dition, some tubular epithelial cells of kidneys from S rats
on 8.0% NaCl diet for 21 days appeared to express both
Fas and FasL (Fig. 4F,G and 4H).
To determine whether the Fas/FasL apoptotic pathway
was active, Western blotting of renal cortical lysates was
performed using an antibody that recognized both pro-
caspase-8 and the active form of caspase-8. In these exper-
iments, active caspase-8 was demonstrated in lysates from
renal cortex of S rats on 8.0% NaCl diet for three weeks
(Fig. 7). Active caspase-8 was not demonstrated in sam-
ples from rats on the diet for 7 days (data not shown). Tis-
sue was also examined for cleavage of Bid, which was
identified specifically in lysates from renal cortex ob-
tained from S rats on 8.0% NaCl diet for three weeks (Fig.
7).
Figure 2
Representative images of immunohistochemical stains of kid-
ney sections from each of the group of rats in the study.
While Fas staining was evident in kidneys from SD rats on
both diets (panels A, B, F, and G) and S rats on 0.3% NaCl
(panels C and H), an increase in staining was observed in kid-
neys from S rats on 8.0% NaCl diet (panels D and I). Staining
was diminished when the antibody was pre-incubated with
soluble Fas (panels E and J). The bar represented 50 µm.BMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/1
Page 6 of 9
(page number not for citation purposes)
Discussion
Recent evidence suggests that apoptosis is involved in sev-
eral pathological processes in the lung [30–32] and kid-
ney [33–37]. Using the Dahl/Rapp salt-sensitive (S) rat,
which develops hypertensive nephrosclerosis that resem-
bles the human disease process [5], this laboratory dem-
onstrated an early and inappropriate apoptotic process
that occurred in both glomerular and tubular compart-
ments of the kidneys and correlated with the decline in
glomerular filtration rate. Apoptosis can be significant
particularly three weeks into the course of hypertensive
nephrosclerosis in this model (Figure 1). A previous study
used RNase protection assay and Western blotting to dem-
onstrate an increase in Fas expression in kidney cortex of
hypertensive S rats. These findings were observed by day
21 of study [7]. The present series of experiments demon-
strated the diffuse sites of expression of Fas and FasL in the
kidney and explored further the possibility that the Fas/
FasL pathway was active during the development of hy-
pertensive renal disease in this rodent model of hyperten-
sion. Expression of both Fas and FasL was observed in
kidneys of both SD and S rats, but specifically increased
over time in hypertensive S rats. Associated with the in-
creased expression was cleavage of procaspase-8 to pro-
duce the active enzyme and cleavage of Bid, indicating
activation of the Fas/FasL apoptotic pathway in the course
of progressive renal failure. These data, along with the pre-
vious studies that confirmed morphological evidence of
apoptosis and biochemical evidence of caspase-3 activa-
tion in these kidneys [7], showed a role for the Fas/FasL
pathway in promoting the loss of kidney function that de-
velops in the setting of hypertensive nephrosclerosis in
this model.
Figure 3
Semi-quantitative analysis of Fas staining showed an increase
(P < 0.05) in expression of Fas by glomerular and tubular
cells from rats on 8.0% NaCl diet for 7 and 21 days (n = 6
rats in each group), compared to the other groups of rats
examined at the same time. Asterisks denote the group that
was different (P < 0.05) than the other three groups from the
same day of study. The increase was prominent on day 21 of
the diet.
Figure 4
Representative higher magnification images of immunohisto-
chemical stain using antibodies to Fas and FasL. Fas stain was
noted in cells in glomeruli (arrowheads, panel A), tubules
(panel B) and arterial smooth muscle (arrows, panel C).
White bar represented 20 µm; L, lumen. FasL expression was
observed in glomerular (panel D) and tubular (panel E) cells,
where expression was prominent particularly on the lumenal
side. Black bars represented 50 and 10 µm, respectively. Co-
expression of both Fas (brown color) and FasL (red color)
was identified in some tubular cells (panels F, G and H). Bar
in panel F represented 100 µm and represented 50 µm in
panels G and H.BMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/1
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The mechanism of augmented Fas and FasL expression in
kidneys of hypertensive S rats is uncertain. In addition to
apoptotic signaling, the Fas/FasL system may also be in-
volved in proliferation. Hueber, et al., showed that Fas
might promote T-cell proliferation by modulating release
of calcium from intracellular stores [38]. FasL is anti-pro-
liferative by regulating cell-cycle progression [39]. Previ-
ous studies demonstrated an increase in cell proliferation
rates in kidneys of S rats on the high-salt diet [7], so it is
possible that Fas and FasL may play a role in control of
proliferation. Another potential explanation is tissue hy-
poxia, which has been suggested to upregulate Fas in the
kidney [36,37]. MDCK cells in culture demonstrated in-
creased expression of Fas, FasL and FADD in response to
partial ATP depletion [40]. Fas and FasL expression in the
kidney may serve as indicators of cellular stress. Tissue hy-
poxia therefore remains a possible mechanism of in-
creased expression of Fas and FasL, although it seems less
likely that the arteriolosclerosis that developed in S kid-
neys was severe enough to produce hypoxic conditions
sufficient to up-regulate Fas, until the third week of study.
Increased expression of Fas and FasL appeared to increase
the propensity to undergo apoptosis, but was not the sole
determinant of this process. Despite the increase in ex-
pression of Fas and FasL at day 7 of study, caspase-8 acti-
vation and Bid cleavage were not observed. Fas/FasL-
mediated apoptotic signaling is modulated by other intra-
cellular factors. Induction of inhibitor of apoptosis pro-
teins (IAP) is one such mechanism [41–43]. In vascular
smooth muscle cells, surface expression of Fas [44] and
molecules involved in signaling the apoptotic process,
such as caspase-8 and caspase-3, appear to be regulated
and provide another level of cellular control of apoptosis
[45]. However, the potential anti-apoptotic mechanisms
present early in the course were ineffective by day 21,
when caspase-8 activation was evident. A previous study
suggested that the apoptotic process occurred early in the
development of hypertension in this model [26], so the
data suggested that an apoptotic mechanism in addition
to activation of the Fas/FasL pathway is also involved in
development of hypertensive nephrosclerosis in S rats.
In conclusion, kidneys of S rats have been shown to be
very sensitive to hypertensive injury, which is mediated at
least in part by the apoptotic mechanism controlled by
Fas. Augmented expression of both Fas and FasL by
Figure 5
Representative images of immunohistochemical stains using
antibody to FasL. Panels A and F represent negative controls,
where the primary antibody was omitted from the reaction.
Expression of FasL did not appear to be altered by dietary
salt in the SD rats, but increased in S rats on the 8.0% NaCl.
The effect was pronounced by the third week of study.
Expression was observed in both glomerular and tubular
compartments of the kidney. Black bar represented 50 µm.
Figure 6
Semi-quantitative analysis of FasL expression in the kidney (n
= 6 rats in each group). Compared with the other three
groups examined at the same time in the study, an increase
(P < 0.05) in FasL staining was observed in glomerular and
tubular cells of S rats on the 8.0% NaCl diet. Asterisks
denote the group that was different (P < 0.05) than the other
three groups from the same day of study. The increase was
prominent by the third week of study.BMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/1
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glomerular and tubular cells resulted in caspase-8 activa-
tion. The pronounced increases in Fas and FasL expression
and activation of this pathway by the third week of study
also correlated with previous evidence that documented
irreversibility of the renal injury if the hypertension was
not corrected by this time [5]. These data supported the
view that the Fas/FasL pathway promoted nephrosclerosis
in this model. Activation of the Fas/FasL pathway may
also serve as a mechanism of tubular epithelial cell loss
and interstitial fibrosis, which are also prominent renal
features of hypertension. The role of the Fas/FasL pathway
in human hypertensive nephrosclerosis remains to be de-
termined.
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